In summary, glucose metabolism dysfunction in the form of hyperinsulinemia, insulin resistance, hyperglycemia, and altered insulin signaling are all metabolic factors that can be individually and holistically linked to Aβ metabolism, and therefore AD risk. This evidence concerns the gene INS and Hyperglycemia.